Nuzenio

Oric Pharmaceuticals Reports

Oric Pharmaceuticals Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 8 publisher sources 100/100 entity strength

Latest news

ORIC Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - MoomooMoomoo · Fri, 07 Aug 2026 23:37:40 GMTEvercore ISI Keeps Their Buy Rating on Oric Pharmaceuticals (ORIC) - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 15:30:00 GMTOric Pharmaceuticals reports Q2 2026 net loss $41.5M, cash $387.6M; Phase 3 trial initiated - TradingViewTradingView · Mon, 03 Aug 2026 20:13:01 GMTORIC® Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Updates - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 20:05:00 GMTORIC Starts Global Prostate Cancer Trial Expected to Enroll About 600 - Stock TitanStock Titan · Mon, 03 Aug 2026 20:05:00 GMTOric Pharmaceuticals (NASDAQ:ORIC) Stock Price Down 5.2% - Should You Sell? - MarketBeatMarketBeat · Mon, 03 Aug 2026 19:35:14 GMTORIC Pharmaceuticals Director Richard Heyman Reports Major Stock Transactions on July 24, 2026 - Kalkine MediaKalkine Media · Tue, 28 Jul 2026 20:55:37 GMTOric Pharmaceuticals (ORIC) director trades options, sells 13,100 shares - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 23:37:40 GMTORIC Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Moomoo
Wed, 05 Aug 2026 15:30:00 GMTEvercore ISI Keeps Their Buy Rating on Oric Pharmaceuticals (ORIC) - The Globe and Mail
Mon, 03 Aug 2026 20:13:01 GMTOric Pharmaceuticals reports Q2 2026 net loss $41.5M, cash $387.6M; Phase 3 trial initiated - TradingView
Mon, 03 Aug 2026 20:05:00 GMTORIC® Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Updates - Yahoo Finance
Mon, 03 Aug 2026 20:05:00 GMTORIC Starts Global Prostate Cancer Trial Expected to Enroll About 600 - Stock Titan
Mon, 03 Aug 2026 19:35:14 GMTOric Pharmaceuticals (NASDAQ:ORIC) Stock Price Down 5.2% - Should You Sell? - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Oric Pharmaceuticals Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.